Group 1 - The core viewpoint of the articles highlights the Chinese government's initiatives to promote high-quality development in the pharmaceutical retail industry, including encouraging participation in centralized procurement and supporting mergers and acquisitions among retail pharmacies [1] - The Chinese pharmaceutical export value reached $100.895 billion in the first 11 months of 2025, indicating a continuous optimization of product structure [1] - Traditional products such as traditional Chinese medicine and chemical active pharmaceutical ingredients maintain a strong global market share, with export scales continuing to grow [4] Group 2 - Chinese pharmaceutical companies set a record of $135.7 billion through multinational licensing agreements in 2025, showing significant year-on-year growth and increasing global recognition of Chinese pharmaceutical innovation [4] - Strengthened cooperation between China and ASEAN has led to the establishment of a pharmaceutical trade regional platform, with transaction volumes exceeding 10 million RMB and attracting 224 companies, thereby promoting regional trade [4] - The platform is built on transparency, regulatory credibility, and public health commitments, serving as a valuable bridge of trust between ASEAN countries and China [4]